AbbVie drug shows promise against difficult type of breast cancer

December 13, 2013 1:45 PM

9 0

AbbVie drug shows promise against difficult type of breast cancer

(Reuters) - Women with an especially deadly type of breast cancer who received a treatment regimen containing an experimental AbbVie Inc drug prior to surgery are likely to have a significantly better response than those who get a standard chemotherapy regimen, according to data from a clinical trial.

Patients with so-called triple negative breast cancer, who tend to be younger and have a very poor prognosis, appeared to have double the response rate to the regimen containing AbbVie's veliparib in a new type of study that exploits advances in molecular understanding of the disease, researchers fo...

Read more

To category page

Loading...